✦ LIBER ✦

W16-O-003 Efficacy and safety of rosuvastatin 40 MG in patients with severe type IIA and IIB hypercholesterolaemia

✍ Scribed by Stein, E.A.; Melezinkova, H.; Le Maulf, F.; Gold, A.

Book ID: 118633477
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 272 KB
Volume: 6
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(05)80394-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Efficacy and Safety of Rosuvas

Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia

✍ Evan A. Stein; John Amerena; Christie M. Ballantyne; Edmund Brice; Michel Farnie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Efficacy and safety of micronised fenofi

Efficacy and safety of micronised fenofibrate and simvastatin in patients with type IIa or IIb dyslipidaemia

✍ G. Crepaldi; A. Barbato; D. Delaval 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 127 KB

EFFICACY AND SAFETY OF EZETIMIBE/SIMVAST

EFFICACY AND SAFETY OF EZETIMIBE/SIMVASTATIN COADMINISTERED WITH EXTENDED RELEASE NIACIN IN PATIENTS WITH TYPE IIA OR IIB HYPERLIPIDEMIA

✍ FAZIO, S; BROWN, B; GUYTON, J; POLIS, A; TOMASSINI, J; TERSHAKOVEC, A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Lipid-Altering Efficacy and Safety of Ez

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia

✍ John R. Guyton; B. Greg Brown; Sergio Fazio; Adam Polis; Joanne E. Tomassini; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Efficacy and safety of rosuvastatin 40&#

Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study

✍ Lawrence A. Leiter; Robert S. Rosenson; Evan Stein; John P.D. Reckless; Karl-Lud 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Efficacy and Safety of Olmesartan Medoxo

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension

✍ Prof Roberto Fogari, Stefano Taddei, Merete Holm-Bentzen, Jacek Baszak, Lorenzo 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 189 KB